Table 1 patiens characteristics

Age, median (range)

29–77(47)

29–65(47)

32–77(47)

Area of treatment

Breast only

34

4

30

Supreclavicular area

12

7

5

Axillary area

6

4

2

Internal mammary LN

5

5

0

Laterality

Left

36

11

25

Right

12

3

9

Bilateral

2

0

2

Histology

Invasive ductal carcinoma

38

13

25

Invasive lobular carcinoma

4

1

3

Mixed

4

0

4

Carcinoma in situ

2

0

2

Other

2

0

2

Estrogen receptor status

Positive

29

6

23

Negative

21

8

13

Progesterone receptor status

Positive

26

5

21

Negative

24

9

15

Her2/neu status

Positive

8

2

6

Negative

42

12

30

Histologic grade

1

7

1

6

2

20

5

15

3

21

8

13

Unknown

2

0

2

Tumor stage

T1

38

10

28

T2

11

3

8

T3

1

1

0

T4

0

0

0

Nodal stage

N0

35

6

29

N1

14

7

7

N2

1

1

0

N3

0

0

0

Pathological stage

Stage

I

26

5

21

II

22

7

15

III

2

2

0

Chemotherapy timing

Adjuvant

37

12

25

Neoadjuvant

2

1

1

None(endocrinotherapy)

11

1

10

Radiation dose

50 Gy

14

–

–

40.05 Gy

36

–

–